Autonomic Neuromodulation by Transcutaneous Nerve Stimulation in Acute Ischaemic Stroke.
- Sponsor
- Queen Mary University of London
- Study ID
- NCT05417009
- Status
- Completed
Conditions
- Autonomic Dysfunction
- Autonomic Imbalance
- Ischemic Stroke
- Thrombotic Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 95 Years
- Healthy Volunteers
- Not accepted
Interventions
- trans-cutaneous auricular sensory stimulation — DEVICETranscutaneous auricular sensory stimulation
Study Details
Autonomic modulation by transcutaneous vagal nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: a phase IIa, sham controlled randomised trial.
Key Dates
- Start date
- Apr 26, 2023
- Status verified
- Jul 2025
- Primary completion
- Jul 21, 2023
- Completion
- Jul 21, 2023
Study Design
- Enrollment
- 36 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: StimulationElectrodes attached bliaterally to tragus nerve region of outer ear, with appropriate device settings to deliver current.
- Sham Comparator: Electrode attachment only.Electrodes attached bliaterally to tragus nerve region of outer ear, with device switched off \[blinded to operator\].
Primary Outcome Measure
Blood Pressure Variability [ Time Frame: 0-24h after mechanical thrombectomy ]
Related Studies
- Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular DisordersRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Stroke Recovery Initiative - Registry for Stroke Research StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Verapamil for Neuroprotection in StrokePHASE1/PHASE2 · Recruiting · Global Neurosciences Institute · Atlantic City, New Jersey
- VNS Prospective Neuromodulation of Immune and Gastrointestinal SystemsRecruiting · University of Louisville · Louisville, Kentucky